Experiences with serum BNP (B type natriuretic peptid) in patients with systolic and diastolic heart failure;Szérum B-típusú natriureticus peptid meghatározással szerzett tapasztalataink izolált bal kamrai systolés és diastolés diszfunkciós betegeken

Orvosi Hetilap

Volumn 146, Issue 37, 2005, Pages 1919-1923

  Lukács, Imre ^a   Fey, Erzsébet ^b   Kárpáti, Pál ^a  

^a I Belgyógyászati Osztály ^*  (Hungary)

^b Kútvölgyi Klinikai Tömb   (Hungary)

Author keywords

BNP; Left atrial volumen; Systolic and diastolic dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

BODY SURFACE; CLINICAL ASSESSMENT; DIAGNOSTIC TEST; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DYSPNEA; ECHOCARDIOGRAPHY; ELASTICITY; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HUMAN; MEDICAL LITERATURE; PROTEIN BLOOD LEVEL; REVIEW; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE; ADULT; AGED; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; DIASTOLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEART STROKE VOLUME; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SYSTOLE;

ADULT; AGED; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DIASTOLE; DYSPNEA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; STROKE VOLUME; SYSTOLE;

EID: 33644644736     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Bold, A. J., Borenstein H. B., Veress, A. T. és mtsai: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci., 1981, 28, 89-94.
2. Browne, M. R., Struthers, A. D., Wood, D. A. és mtsai: Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet, 1997, 350, 1349-1353.
3. Dalström, U.: Can natriuretic peptide be used for diagnosis of diastolic heart failure? Eur. J. Heart Failure, 2004, 6, 281-287.
4. Darbar, D., Davidson, N. C., Gillespie, A. és mtsai: Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am. J. Cardiol., 1996, 78, 284-287.
5. Fukuda, N., Shinohara, H., Sakabe, K.: Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. J. Heart Valve Dis., 2003, 12, 333-340.
6. Gackowski, A., Isnard, R., Golmard, J.-L. és mtsai: Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur. Heart J. 2004, 25, 1788-1796.
7. Hall, C.: Essential biochemistry and physiology of (NT-pro) BNP. Eur. J. Heart Failure. 2004, 6, 257-260.
8. Hartman, F., Packer, M., Coats, A. J. S.: NT-pro BNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-pro BNP substudy. Eur. J. Heart Fail., 2004, 6, 343-350.
9. Lemos, J. A., Mcguire, K. D., Drazner, M. H.: B-type natriuretic peptid in cardiovascular disease. Lancet, 2003, 362, 316-322.
10. Lengyel M.: Diastologia és pitvarfibrillatio-2004. Kardiologus kongresszus, 2004, 2, 13-20.
11. Lengyel M., Farsang Cs., Zorándi, A.: Idoskori diastolés szívelégtelenség hospitalizált betegeken. Cardiológia Hung., 2004, 34, 109-113.
12. Lim, P., Monin, J. L., Monchi, M.: Predictors of outcome in severe aortic stenosis with normal left ventricular function: role of B-type Natriuretic peptide. Eur. Heart. J. 2004, 25, 2048-2053.
13. Logeart, D., Saudubray, C., Beyne P. és mtsai: Comperative value of doppler echocardiography and B-type natriuretic peptide assay in etiologic diagnosis of acute dyspnea. J. Amer. Coll. Cardiol., 2002, 40, 1794-1800.
14. Mair, J., Hammerer-Lercher, A., Puschendorf, B.: The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin. Chem., Lab., 2001, 39, 571-588.
15. McKee, P. A., Castelli, W. P., McNamara, P. M.: The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med., 1971, 285, 1441-1446.
16. Motwani, J. G., McAlpine, H., Kennedy, N.: Plasma brain natriuretic peptide as indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet, 1993, 341, 1109-1113.
17. Nagaya, N., Nishikimi, T., Okano, Y.: Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricul dysfunction in pulmonary hypertension. J. Am. Coll. Cardiol., 1998, 31, 202-208.
18. Packer, M.: Should B-type natriuretic peptide be measure routinely to guide the diagnosis and management of chronic heart failure. Circulation, 2003, 108, 2950-2953.
19. Richards, A. M.: B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation, 2003, 107, 2786-2792.
20. Szelid Zs. Sz.: NT-proBNP jelentosége szívclé gtelenség diagnózisában és a prognózis megítélésében. Kardiológus, 2003, 4, 45-46.
21. Talwar, S., Squire, I. B., Downie, P. F. és mtsai: Profile of plasma N-termmal proBNP following acute myocardial infraction. Eur. Heart J., 2000, 21, 1514-1521.
22. Tang, W. W. H., Girod, J. P., Lee, M. J.: Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation, 2003, 108, 2964-2966.
23. Tomcsányi, I., Nagy, E., Somlói, M. és mtsai: NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exsudates Eur. J. Heart Failure 2004, 6, 753-756.
24. Troughton, R. W., Frampton, C. M., Yandle, T. G.: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet, 2000, 355, 1126-1130.
25. Tsang, T. S. M., Barnes, M. E., Baely, K. R. és mtsai: Left atrial volumen: important risk marker of incident atrial fibrillation 1655 older men and women. Mayo Clin. Proc., 2001, 76, 467-475.
26. Vanderheyden, M., Bartunek, J., Gothals, M.: Brain and other natriuretic peptids: molecular aspects. Eur. J. Heart Failure, 2004, 6, 261-268.
27. Vasan, R. S., Levy; D.: Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation, 2000, 101, 2118-2121.
28. Wang, M., Yip, G. W. K., Zhang, Y. és mtsai: Peak early diastolic annular velocity by tissue Doppler imaging adds independent and incremental prognostic value. J. Am. Coll. Cardiol, 2003, 41, 820-826.
29. Yu, C. M., Sandrson, J. E., Shum, I. O.: Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur. Heart J., 1996, 17, 1694-702.
30. Yu, C. M., Sandorsen, J. E.: Plasma brain natriuretic peptide and independent predictor of cardiovascular mortality in acute heart failure. Eur. J. Heart Fail., 1999, 1, 59-65.